Clinical Supply Regulation Resources
-
Leveraging The Bolar Exemption To Accelerate Market Access
3/17/2023
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.
-
Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes
6/1/2022
Explore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
7/11/2025
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
Quality Assured: Bringing Life-Changing Therapies To Patients
1/12/2023
Biopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
Vertex On Building Risk Into Manufacturing Network Strategy
9/17/2026
Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.
-
The Critical Role Of Clinical Trial Packaging Services In Trial Success
1/26/2026
Compliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.
-
Decentralized Clinical Trials: A Win For Patients, Sponsors, & Investigators
Learn how the integral role of Direct-to-Patient Services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.
-
IMP Labeling: EU CTR Transition Considerations
6/26/2023
Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
IQVIA Labeling Compliance Solutions
5/16/2023
Learn how by having a strategy for “core-to-carton” compliance, drug developers can avoid risks for patients and their company.
-
A Practical Packaging Components Checklist For Emerging Biotechs
6/20/2024
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.